Other thrombophilia
ICD-10 D68.69 is a billable code used to indicate a diagnosis of other thrombophilia.
Other thrombophilia refers to a group of conditions characterized by an increased tendency to form blood clots due to various underlying factors that are not classified under more specific thrombophilia codes. These conditions can arise from genetic mutations, acquired factors, or a combination of both. Common causes include deficiencies in natural anticoagulants such as protein C, protein S, and antithrombin III, as well as the presence of antiphospholipid syndrome. Patients with other thrombophilia may experience recurrent venous thromboembolism (VTE), which can lead to serious complications such as pulmonary embolism or post-thrombotic syndrome. The diagnosis often requires a thorough clinical evaluation, including a detailed patient history, laboratory tests to assess coagulation factors, and possibly genetic testing. Management typically involves anticoagulation therapy, lifestyle modifications, and monitoring for potential complications. Accurate coding is essential for proper treatment and reimbursement, as well as for tracking the epidemiology of these conditions.
Detailed lab results, patient history, and treatment plans.
Patients presenting with recurrent DVT or PE, unexplained thrombosis.
Ensure all relevant coagulation studies are documented to support diagnosis.
Comprehensive patient history and risk factor assessment.
Management of patients with known thrombophilia and comorbid conditions.
Document any anticoagulation therapy adjustments and patient education.
Used to evaluate patients with suspected thrombophilia.
Document the reason for the CBC and any relevant findings.
Hematology specialists should ensure all relevant lab results are included.
D68.69 is used when the specific type of thrombophilia is not documented, while other codes specify particular conditions like antiphospholipid syndrome.
